-
1
-
-
84863393080
-
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing
-
Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012;366:883-92.
-
(2012)
N Engl J Med
, vol.366
, pp. 883-892
-
-
Gerlinger, M.1
Rowan, A.J.2
Horswell, S.3
-
2
-
-
84884407337
-
Tumour heterogeneity in the clinic
-
Bedard PL, Hansen AR, Ratain MJ, et al. Tumour heterogeneity in the clinic. Nature 2013;501:355-64.
-
(2013)
Nature
, vol.501
, pp. 355-364
-
-
Bedard, P.L.1
Hansen, A.R.2
Ratain, M.J.3
-
3
-
-
84980332141
-
Liquid Biopsy in Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society
-
Sholl LM, Aisner DL, Allen TC, et al. Liquid Biopsy in Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society. Arch Pathol Lab Med 2016;140:825-9.
-
(2016)
Arch Pathol Lab Med
, vol.140
, pp. 825-829
-
-
Sholl, L.M.1
Aisner, D.L.2
Allen, T.C.3
-
4
-
-
84901604272
-
Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing
-
Wong SQ, Li J, Tan AY, et al. Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing. BMC Med Genomics 2014;7:23.
-
(2014)
BMC Med Genomics
, vol.7
, pp. 23
-
-
Wong, S.Q.1
Li, J.2
Tan, A.Y.3
-
5
-
-
85015462482
-
Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine?
-
Ilie M, Hofman V, Long E, et al. Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine? Ann Transl Med 2014;2:107.
-
(2014)
Ann Transl Med
, vol.2
, pp. 107
-
-
Ilie, M.1
Hofman, V.2
Long, E.3
-
6
-
-
84898542288
-
Liquid biopsies: genotyping circulating tumor DNA
-
Diaz LA Jr, Bardelli A. Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol 2014;32:579-86.
-
(2014)
J Clin Oncol
, vol.32
, pp. 579-586
-
-
Diaz L.A, Jr.1
Bardelli, A.2
-
7
-
-
84995573375
-
Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer
-
Nilsson RJ, Karachaliou N, Berenguer J, et al. Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer. Oncotarget 2016;7:1066-75.
-
(2016)
Oncotarget
, vol.7
, pp. 1066-1075
-
-
Nilsson, R.J.1
Karachaliou, N.2
Berenguer, J.3
-
8
-
-
84863000299
-
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
-
Diaz LA Jr, Williams RT, Wu J, et al. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature 2012;486:537-40.
-
(2012)
Nature
, vol.486
, pp. 537-540
-
-
Diaz L.A, Jr.1
Williams, R.T.2
Wu, J.3
-
9
-
-
84906250256
-
Gefitinib treatment in EGFR mutated caucasian NSCLC: circulating-free tumor DNA as a surrogate for determination of EGFR status
-
Douillard JY, Ostoros G, Cobo M, et al. Gefitinib treatment in EGFR mutated caucasian NSCLC: circulating-free tumor DNA as a surrogate for determination of EGFR status. J Thorac Oncol 2014;9:1345-53.
-
(2014)
J Thorac Oncol
, vol.9
, pp. 1345-1353
-
-
Douillard, J.Y.1
Ostoros, G.2
Cobo, M.3
-
10
-
-
84938399710
-
Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy
-
Mok T, Wu YL, Lee JS, et al. Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy. Clin Cancer Res 2015;21:3196-203.
-
(2015)
Clin Cancer Res
, vol.21
, pp. 3196-3203
-
-
Mok, T.1
Wu, Y.L.2
Lee, J.S.3
-
11
-
-
84928739294
-
AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer
-
Jänne PA, Yang JC, Kim DW, et al. AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer. N Engl J Med 2015;372:1689-99.
-
(2015)
N Engl J Med
, vol.372
, pp. 1689-1699
-
-
Jänne, P.A.1
Yang, J.C.2
Kim, D.W.3
-
12
-
-
84937414146
-
Heterogeneity Underlies the Emergence of EGFRT790 Wild-Type Clones Following Treatment of T790MPositive Cancers with a Third-Generation EGFR Inhibitor
-
Piotrowska Z, Niederst MJ, Karlovich CA, et al. Heterogeneity Underlies the Emergence of EGFRT790 Wild-Type Clones Following Treatment of T790MPositive Cancers with a Third-Generation EGFR Inhibitor. Cancer Discov 2015;5:713-22.
-
(2015)
Cancer Discov
, vol.5
, pp. 713-722
-
-
Piotrowska, Z.1
Niederst, M.J.2
Karlovich, C.A.3
-
13
-
-
84962222188
-
Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses
-
Sundaresan TK, Sequist LV, Heymach JV, et al. Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses. Clin Cancer Res 2016;22:1103-10.
-
(2016)
Clin Cancer Res
, vol.22
, pp. 1103-1110
-
-
Sundaresan, T.K.1
Sequist, L.V.2
Heymach, J.V.3
-
14
-
-
84877579861
-
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
-
Murtaza M, Dawson SJ, Tsui DW, et al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 2013;497:108-12.
-
(2013)
Nature
, vol.497
, pp. 108-112
-
-
Murtaza, M.1
Dawson, S.J.2
Tsui, D.W.3
-
16
-
-
84975461688
-
Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer
-
Sacher AG, Paweletz C, Dahlberg SE, et al. Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer. JAMA Oncol 2016;2:1014-22.
-
(2016)
JAMA Oncol
, vol.2
, pp. 1014-1022
-
-
Sacher, A.G.1
Paweletz, C.2
Dahlberg, S.E.3
-
17
-
-
79951849235
-
Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker
-
Hofman V, Bonnetaud C, Ilie MI, et al. Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker. Clin Cancer Res 2011;17:827-35.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 827-835
-
-
Hofman, V.1
Bonnetaud, C.2
Ilie, M.I.3
-
18
-
-
84868109046
-
ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma
-
Ilie M, Long E, Butori C, et al. ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma. Ann Oncol 2012;23:2907-13.
-
(2012)
Ann Oncol
, vol.23
, pp. 2907-2913
-
-
Ilie, M.1
Long, E.2
Butori, C.3
-
19
-
-
84974824198
-
Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study
-
Morrow CJ, Trapani F, Metcalf RL, et al. Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study. Ann Oncol 2016;27:1155-60.
-
(2016)
Ann Oncol
, vol.27
, pp. 1155-1160
-
-
Morrow, C.J.1
Trapani, F.2
Metcalf, R.L.3
-
20
-
-
84910008796
-
"Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease
-
Ilie M, Hofman V, Long-Mira E, et al. "Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease. PLoS One 2014;9:e111597.
-
(2014)
PLoS One
, vol.9
-
-
Ilie, M.1
Hofman, V.2
Long-Mira, E.3
|